Safety, Reactogenicity & Immunogenicity Study to Evaluate a Booster Dose of GSK Biologicals' Hib-MenC Given With Priorix™ in Toddlers (13-14 m) Primed With 3 Doses of Hib and MenC-CRM197

Name: Safety, Reactogenicity & Immunogenicity Study to Evaluate a Booster Dose of GSK Biologicals' Hib-MenC Given With Priorix™ in Toddlers (13-14 m) Primed With 3 Doses of Hib and MenC-CRM197
License: Public Domain

GlaxoSmithKline

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

haemophilus influenzae type b, neisseria meningitidis

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 208294
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.